Why in News: NASA announced plans to launch a pair of missions to Venus between 2028 and 2030 About the mission To study the atmosphere and geologic features of Venus and better understand why Earth and Venus emerged so differently. …
Why in News: Intel Corp’s CEO said it could take several years for a global shortage of semiconductors to be resolved, a problem that has shuttered some auto production lines and is also being felt in other areas, including consumer …
Why in News: The first total lunar eclipse in more than two years coincided with a supermoon. What is a Lunar Eclipse? A lunar eclipse occurs when the moon passes directly behind the earth into its shadow. The earth, sun …
Why in News? Lawmakers, child rights activists and medical experts are raising the alarm against Instagram’s plan to launch a service targeted at children, stating risks to their physical, mental and emotional wellbeing. About the move Facebook-owned Instagram is said …
Why in News: India Meteorological Department (IMD) has announced that Cyclone Yaas is likely to intensify into a “very severe cyclonic storm”. What is a cyclone? Cyclones are caused by atmospheric disturbances around a low-pressure area distinguished by swift and …
Why in News: The Union government has asked the States to declare mucormycosis, the fungal infection being reported in COVID-19 patients, an epidemic. What is Mucormycosis? Mucormycosis or black fungus is an aggressive and invasive fungal infection caused by a …
Why in News? As per a study published in the journal “Proceedings of the National Academy of Science”, the warming Arctic tundra will make it harder for the world to curb climate change, as thawing permafrost and wildfires release greenhouse …
Why in News? China landed a spacecraft on Mars carrying its first Mars rover. About China’s Mars Program China had in 2020 launched its first Mars mission, called Tianwen-1, carrying a lander and rover. Tianwen-1 had been in orbit and …
What is Plasma Therapy for COVID-19? Plasma Therapy involves transfusion of antibodies from someone who has recovered from COVID-19 into a critical patient. The therapy is based on the principle that the blood of a recovered patient is rich in …